Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis (Q34349522)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Lars-Olof Wahlund

5

object named as

Lars-Olof Wahlund

0 references

Daniel Ferreira

object named as

Daniel Ferreira

1

0 references

object named as

Eric Westman

4

0 references

Lilisbeth Perestelo-Pérez

3

object named as

Lilisbeth Perestelo-Pérez

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Pedro Serrano-Aguilar

7

object named as

Pedro Serrano-Aguilar

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Amado Rivero-Santana

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Antonio Sarría

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

16 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Frontiers in Aging Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

287

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF biomarkers for Alzheimer's disease: current utility and potential future use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF Biomarkers for Alzheimer's Disease Diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment as a diagnostic entity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Current concepts in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Multicenter clinicopathological correlation in dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Revised criteria for mild cognitive impairment: validation within a longitudinal population study.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF biomarker levels in early and late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Cerebrospinal fluid markers for prediction of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

[Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer's disease].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

27 October 2018

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

27 October 2018

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detecting and describing heterogeneity in meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers of Alzheimer's disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FNAGI.2014.00287

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34349522&oldid=1746338882"